-
Mashup Score: 16Hepatic inflammatory responses in liver fibrosis - 4 month(s) ago
Chronic liver diseases such as nonalcoholic fatty liver disease (NAFLD) or viral hepatitis are characterized by persistent inflammation and subsequent liver fibrosis. Liver fibrosis critically determines long-term morbidity (for example, cirrhosis or liver cancer) and mortality in NAFLD and nonalcoholic steatohepatitis (NASH). Inflammation represents the concerted response of various hepatic cell…
Source: www.nature.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 1Managing Lupus Nephritis: Importance of Immunosuppression and Mitigation of Tissue Fibrosis | Lupus Science and Medicine Podcast - 6 month(s) ago
Dr. Anna Wolska from the Lupus Foundation of America interviews Drs. Ana Malvar and Brad Rovin. They discuss using repeat tissue biopsies to understand progression of lupus nephritis over time. They offer conjecture that both immunosuppression as well as mitigation of tissue fibrosis, resulting from inflammatory resolution, are needed in order to preserve kidney function and prevent progression to kidney failure. Read the related article – http://dx.doi.org/10.1136/lupus-2023-000932
Source: lupusbmj.podbean.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Managing Lupus Nephritis: Importance of Immunosuppression and Mitigation of Tissue Fibrosis | Lupus Science and Medicine Podcast - 7 month(s) ago
Dr. Anna Wolska from the Lupus Foundation of America interviews Drs. Ana Malvar and Brad Rovin. They discuss using repeat tissue biopsies to understand progression of lupus nephritis over time. They offer conjecture that both immunosuppression as well as mitigation of tissue fibrosis, resulting from inflammatory resolution, are needed in order to preserve kidney function and prevent progression to kidney failure. Read the related article – http://dx.doi.org/10.1136/lupus-2023-000932
Source: lupusbmj.podbean.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0The effect of elexacaftor/tezacaftor/ivacaftor on non-pulmonary symptoms in adults with cystic fibrosis - 7 month(s) ago
Elexacaftor/Tezacaftor/Ivacaftor (ETI) is a CFTR modulator that has led to large benefits in lung function, pulmonary exacerbation rates, and respirat…
Source: www.sciencedirect.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Lysophosphatidic acid receptor 1 antagonist slows lung function decline in progressive PF - 7 month(s) ago
Receiving an oral lysophosphatidic acid receptor 1 antagonist for 26 weeks lowered the rate of percent predicted FVC decline in progressive pulmonary fibrosis, according to a European Respiratory Society International Congress presentation.“Lysophosphatidic A and its receptor, LPA1, are involved in wound healing and have been implicated now in the pathogenesis of fibrotic diseases overall
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 1Managing Lupus Nephritis: Importance of Immunosuppression and Mitigation of Tissue Fibrosis | Lupus Science and Medicine Podcast - 7 month(s) ago
Dr. Anna Wolska from the Lupus Foundation of America interviews Drs. Ana Malvar and Brad Rovin. They discuss using repeat tissue biopsies to understand progression of lupus nephritis over time. They offer conjecture that both immunosuppression as well as mitigation of tissue fibrosis, resulting from inflammatory resolution, are needed in order to preserve kidney function and prevent progression to kidney failure. Read the related article – http://dx.doi.org/10.1136/lupus-2023-000932
Source: lupusbmj.podbean.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Survival similar in lung transplantation for COVID-19-related ARDS, pulmonary fibrosis - 7 month(s) ago
Patients with COVID-19-related acute respiratory distress syndrome undergoing transplantation had comparable, high survival rates to patients with COVID-19-related pulmonary fibrosis, according to results published in JAMA Surgery.Further, survival rates from these patients did not differ from those of patients who underwent lung transplantation for a non-COVID-19-related reason, according to
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 3Does knowledge of liver fibrosis affect high-risk drinking behaviour (KLIFAD): an open-label pragmatic feasibility randomised controlled trial - 8 month(s) ago
Integration of transient elastography in community alcohol services is feasible. It may improve engagement with services, retention in clinical trials and supplement the reduction in self-reported alcohol consumption. A definitive RCT is supported.
Source: www.thelancet.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
📰New RCT: Does knowledge of #liver #fibrosis affect high-risk drinking behaviour? Integration of transient elastography in community alcohol services may improve engagement with services and supplement the reduction in self-reported alcohol consumption https://t.co/fuDDGUIca7 https://t.co/WVE39gQni2
-
-
Mashup Score: 0Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options - 9 month(s) ago
Abstract. The prevalence of non-alcoholic fatty liver disease (NAFLD) is continually increasing due to the global obesity epidemic. NAFLD comprises a systemic m
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Objectives Systemic Sclerosis (SSc) has the highest mortality rate among the rheumatic diseases, with lung fibrosis leading as the cause of death. A characteristic of severe SSc-related lung fibrosi…
Source: onlinelibrary.wiley.comCategories: General Medicine News, Latest HeadlinesTweet
2023 journal countdown - our Oct issue was a Focus on liver #fibrosis, and was inspired by this REVIEW on hepatic inflammatory responses in liver fibrosis https://t.co/nA8ajv8HhF https://t.co/bw7w1svqDC